Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/461)
- Goga, A, Soussi, G, Mogenet, A, Habert, P, Fourdrain, A, Naud, R et al.. Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile. Lung Cancer. 2026;215 :109379. doi: 10.1016/j.lungcan.2026.109379. PubMed PMID:41887129 .
- Duong, QH, Le, TK, Tran, TT, Audebert, S, Camoin, L, Nguyen, NG et al.. HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies. J Exp Clin Cancer Res. 2026; :. doi: 10.1186/s13046-026-03695-6. PubMed PMID:41877198 .
- Cherrak, C, Guerra, X, Panneau, J, Vidal, V, Golzarian, J, Dariane, C et al.. Prostatic artery embolization for benign prostatic hyperplasia: State of the art. Diagn Interv Imaging. 2026; :. doi: 10.1016/j.diii.2026.03.002. PubMed PMID:41866253 .
- Maisons, V, Nassar, N, Cottier, JP, Barbet, C, Sautenet, B, Mercier, E et al.. Reversible cerebral lesions in adult STEC-associated hemolytic uremic syndrome. Kidney Int. 2026;109 (4):798. doi: 10.1016/j.kint.2025.08.047. PubMed PMID:41864670 .
- Baboudjian, M, Sordelli, F, Patard, JJ, Moussi, B, Graffeille, V, Basset, V et al.. Targeted and Perilesional or Systematic Biopsies in Prostate Cancer: The TARGET Clinical Trial Protocol. Eur Urol Oncol. 2026; :. doi: 10.1016/j.euo.2026.02.003. PubMed PMID:41813528 .